Innovative therapeutics

Investors

NASDAQBMRN
FormDescriptionDateFormat
4Statement of changes in beneficial ownership of securitiesJan 9, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJan 4, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJan 4, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJan 2, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 18, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 4, 2017View HTMLDownload DOCDownload PDF
4/AAmendment to a previously filed 4Oct 13, 2017View HTMLDownload DOCDownload PDF
4/AAmendment to a previously filed 4Oct 13, 2017View HTMLDownload DOCDownload PDF
4/AAmendment to a previously filed 4Oct 13, 2017View HTMLDownload DOCDownload PDF
4/AAmendment to a previously filed 4Oct 13, 2017View HTMLDownload DOCDownload PDF
4/AAmendment to a previously filed 4Oct 13, 2017View HTMLDownload DOCDownload PDF
3Initial filing by director officer or owner of more than ten percent.Oct 3, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesOct 3, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesOct 2, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 26, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 19, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 19, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 27, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 23, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 20, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 20, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 13, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 9, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 8, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 8, 2017View HTMLDownload DOCDownload PDF
1-25      26-50      51-75      76-96

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information